Literature DB >> 11979392

Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy.

Andreas Ritsch1, Susanne Kaser, Birgit Volgger, Elisabeth Abfalter, Wolfgang Sturm, Hannes Gänzer, Bernhard Föger, Rudolf Kirchmair, Christoph Ebenbichler, Josef R Patsch.   

Abstract

To study possible mechanisms for the suggested protective effect of hormone-replacement therapy (HRT) with respect to cardiovascular disease we investigated lipoprotein parameters, mass and activity of lipoprotein-metabolizing enzymes, magnitude of postprandial lipemia, and vascular endothelial function in 13 postmenopausal women. All patients were examined before and 3 months after implementation of HRT with estrogen alone (group A, n = 6) or estrogen plus gestagen (group B, n = 7). HRT (groups A and B) resulted in enhanced total transfer of cholesteryl ester (CE) from high-density lipoprotein (HDL) to apolipoprotein B (apoB)-containing lipoproteins (56% +/- 11.45% v 50.82% +/- 13.68%, P <.05) and increased apoA-I plasma concentration (171 +/- 30 v 147 +/- 22 mg/dL, P <.05). Fasting triglycerides (TG) were increased (134 +/- 40 v 115 +/- 39 mg/dL, P <.05). In group A patients the magnitude of postprandial lipemia increased significantly (1,737 +/- 756 v 1,475 +/- 930 mg TG/dL plasma/8 h, P <.05) without any change in lipoprotein lipase (LPL) activity, but with a concomitant decrease in low-density lipoprotein (LDL) size. In both groups flow-mediated dilation (FMD) reflecting vascular endothelial function was not influenced, suggesting that HRT may not directly affect vascular function but rather alters lipoprotein metabolism. The increase of apoA-I was not accompanied by an equivalent rise of HDL cholesterol. Based on the present data this finding can be readily explained by an increase in CE transfer from HDL to TG-rich lipoproteins, which is not due to increased cholesteryl ester transfer protein (CETP) plasma levels, but rather reflects an increase in fasting and postprandial TG. In conclusion, the net effect of accelerated CE transfer due to HRT depends on the balance of proatherogenic aspects, like the generation of small dense LDL, and antiatherogenic aspects, like the stimulation of reverse cholesterol transport. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979392     DOI: 10.1053/meta.2002.31991

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.

Authors:  Ivan Tancevski; Sasa Frank; Petra Massoner; Ursula Stanzl; Wilfried Schgoer; Andreas Wehinger; Catherine Fievet; Philipp Eller; Josef R Patsch; Andreas Ritsch
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

2.  The impact of oral contraceptives on cardiometabolic parameters.

Authors:  M Farahmand; F Ramezani Tehrani; M Rostami Dovom; S Hashemi; F Azizi
Journal:  J Endocrinol Invest       Date:  2015-07-30       Impact factor: 4.256

3.  Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome.

Authors:  Martha A Sánchez-Rodríguez; Mariano Zacarías-Flores; Lizett Castrejón-Delgado; Ana Karen Ruiz-Rodríguez; Víctor Manuel Mendoza-Núñez
Journal:  Int J Mol Sci       Date:  2016-08-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.